RETHINK ACROMEGALY

Serial Number 98547391
Registration 7822254
700

Registration Progress

Application Filed
May 13, 2024
Under Examination
Approved for Publication
Apr 22, 2025
Published for Opposition
Apr 22, 2025
Registered
Jun 10, 2025

Trademark Image

RETHINK ACROMEGALY

Basic Information

Serial Number
98547391
Registration Number
7822254
Filing Date
May 13, 2024
Registration Date
June 10, 2025
Published for Opposition
April 22, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 10, 2025
Registration
Registered
Classes
009 035 041 042
+1 more

Rights Holder

CHIESI FARMACEUTICI S.P.A.

09
Address
Via Palermo, 26 A
Parma (PR) I-43122
IT

Ownership History

CHIESI FARMACEUTICI S.P.A.

Original Applicant
09
Parma (PR) IT

CHIESI FARMACEUTICI S.P.A.

Owner at Publication
09
Parma (PR) IT

CHIESI FARMACEUTICI S.P.A.

Original Registrant
09
Parma (PR) IT

Legal Representation

Attorney
Anthony P. Venturino

USPTO Deadlines

Next Deadline
2140 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-06-10)
Due Date
June 10, 2031
Grace Period Ends
December 10, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

24 events
Date Code Type Description Documents
Jun 10, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 10, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 22, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 22, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 16, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 18, 2025 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Feb 28, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 27, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 27, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 27, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Feb 27, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jan 7, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 7, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 7, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 18, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 18, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 18, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 22, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 22, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 22, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 21, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 14, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 14, 2024 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
May 13, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 009
Downloadable electronic publications in the nature of medical guides in the field of ACROMEGALY disease
First Use Anywhere: Feb 29, 2024
First Use in Commerce: Feb 29, 2024
Class 035
Promoting public awareness of ACROMEGALY disease
First Use Anywhere: Feb 29, 2024
First Use in Commerce: Feb 29, 2024
Class 041
Education services, namely, providing non-downloadable webinars on the topics of ACROMEGALY disease and healthcare
First Use Anywhere: Feb 29, 2024
First Use in Commerce: Feb 29, 2024
Class 042
Providing scientific information in the field of medical disorders and their treatment
First Use Anywhere: Feb 29, 2024
First Use in Commerce: Feb 29, 2024
Class 044
Providing a website featuring information about health, namely, ACROMEGALY disease, medical care and health care; providing health and educational information about ACROMEGALY disease; Medical services; Providing health information; Providing medical information in the healthcare sector; Human healthcare services, namely, disease management programs; support services for people affected by genetic diseases, namely, providing an internet-based database of patient medical information where patients can inquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community; Medical information; Information services relating to health care
First Use Anywhere: Feb 29, 2024
First Use in Commerce: Feb 29, 2024

Additional Information

Design Mark
The mark consists of the wording "RETHINK" in stylized form in pink, the wording "ACROMEGALY" in stylized form in grey below the wording "RETHINK" and an arrow head pointing right in pink on right side of those wordings.
Color Claim
The color(s) pink and grey is/are claimed as a feature of the mark.

Classification

International Classes
009 035 041 042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"ACROMEGALY"